|
1
|
Turkistanli EC, Sogukpinar N, Saydam BK
and Aydemir G: Cervical cancer prevention and early detection-the
role of nurses and midwives. Asian Pac J Cancer Prev. 4:15–21.
2003.PubMed/NCBI
|
|
2
|
Shi YR, Liu J, He W and Yang Y: Expression
of Micro-RNA 218 in cervical cancer and its effect on
proliferation, apoptosis and invasion of HeLa cells. Sichuan Da Xue
Xue Bao Yi Xue Ban. 47:697–702. 2016.(In Chinese). PubMed/NCBI
|
|
3
|
Jung S, Yi L, Kim J, Jeong D, Oh T, Kim
CH, Kim CJ, Shin J, An S and Lee MS: The role of vimentin as a
methylation biomarker for early diagnosis of cervical cancer. Mol
Cells. 31:405–411. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen Y, Chen H, Gao L, Zhang W, He J, Yang
X, Qin L, Xue X and Guo Z: MiR-638 acts as a tumor suppressor gene
in gastric cancer. Oncotarget. 8:108170–108180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang WN, Li W, Wang XL, Hu Z, Zhu D, Ding
WC, Liu D, Li KZ, Ma D and Wang H: CLDN1 expression in cervical
cancer cells is related to tumor invasion and metastasis.
Oncotarget. 7:87449–87461. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang X, Da M, Zhang W, Qi Q, Zhang C and
Han S: Role of Lactobacillus in cervical cancer. Cancer Manag Res.
10:1219–1229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen H, Fan Y, Xu W, Chen J, Meng Y, Fang
D and Wang J: Exploration of miR-1202 and miR-196a in human
endometrial cancer based on high throughout gene screening
analysis. Oncol Rep. 37:3493–3501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McMullen JRW, Selleck M, Wall NR and
Senthil M: Peritoneal carcinomatosis: limits of diagnosis and the
case for liquid biopsy. Oncotarget. 8:43481–43490. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Q, Han LR, Zhou YX and Li Y: MiR-195
Suppresses cervical cancer migration and invasion through targeting
Smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan JJ, Chang Y, Zhang YN, Lin JS, He XX
and Huang HJ: miR-195 inhibits cell proliferation via targeting
AEG-1 in hepatocellular carcinoma. Oncol Lett. 13:3118–3126. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nadeem F, Hanif M, Ahmed A, Jamal Q and
Khan A: Clinico-pathological features associated to MiRNA-195
expression in patients with breast cancer: evidence of a potential
biomarker. Pak J Med Sci. 33:1242–1247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou
Y, Wang Y, Liu L and Zhang Y: GDPD5, a target of miR-195-5p, is
associated with metastasis and chemoresistance in colorectal
cancer. Biomed Pharmacother. 101:945–952. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Z, Liu X, Hu K and Zhang F: The
clinical value of PET and PET/CT in the diagnosis and management of
suspected cervical cancer recurrence. Nucl Med Commun. 39:97–102.
2018.PubMed/NCBI
|
|
16
|
Lv KT, Liu Z, Feng J, Zhao W, Hao T, Ding
WY, Chu JP and Gao LJ: MiR-22-3p regulates cell proliferation and
inhibits cell apoptosis through targeting the eIF4EBP3 gene in
human cervical squamous carcinoma cells. Int J Med Sci. 15:142–152.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
George OL and Ness SA: Situational
awareness: Regulation of the myb transcription factor in
differentiation, the cell cycle and oncogenesis. Cancers (Basel).
6:2049–2071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du B, Zhang P, Tan Z and Xu J: MiR-1202
suppresses hepatocellular carcinoma cells migration and invasion by
targeting cyclin dependent kinase 14. Biomed Pharmacother.
96:1246–1252. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Z, Wang H, Wang Z and Cai H: MiR-195
inhibits the proliferation of human cervical cancer cells by
directly targeting cyclin D1. Tumour Biol. 37:6457–6463. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mou Z, Xu X, Dong M and Xu J:
MicroRNA-148b acts as a tumor suppressor in cervical cancer by
inducing G1/S-phase cell cycle arrest and apoptosis in a
caspase-3-dependent manner. Med Sci Monit. 22:2809–2815. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wipperman J, Neil T and Williams T:
Cervical cancer: evaluation and management. Am Fam Physician.
97:449–454. 2018.PubMed/NCBI
|
|
22
|
Philp L, Jembere N, Wang L, Gao J, Maguire
B and Kupets R: Pap tests in the diagnosis of cervical cancer: help
or hinder? Gynecol Oncol. 150:61–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
